Ark Biosciences
↗Shanghai, China
Ark Biosciences is a global clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative drugs for unmet medical needs, particularly in respiratory and pediatric diseases. The company has established a robust R&D engine and a differentiated pipeline of small molecules and biologics.
Ark's lead program, Ziresovir, is a first-in-class RSV fusion inhibitor that has successfully completed Phase 3 clinical trials, marking a significant milestone as the first oral antiviral to show efficacy in infants with RSV. The company also markets and develops treatments for ADHD and idiopathic pulmonary fibrosis (IPF), leveraging strategic partnerships with global leaders like Roche and Calibr.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Infectious Disease & Respiratory Therapeutics
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M
Founded:2014
Ownership:private
Status:operating
FUNDING
Stage:Series D
Total Raised:$230M
Investors:TPG Capital, Decheng Capital, Loyal Valley Capital, Qiming Venture Partners, Yuanhe Holdings, Free Trade Zone Fund
PIPELINE
Stage:Commercial
Lead Drug Stage:NDA Filed / Approved
Modalities:Small molecule, Monoclonal antibody (mAb)
Active Trials:8
Trial Phases:Phase 1: 3 | Phase 2: 3 | Phase 3: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Ark Biosciences Private Limited (India), ArkBio US Office
Key Partnerships:Roche (Licensing of Ziresovir), Calibr (Co-development of AK0705), Partex (AI-driven drug discovery), Wuxi STA (Commercial supply for Ziresovir)
COMPETITION
Position:Leader
Competitors:ReViral (acquired by Pfizer), Enanta Pharmaceuticals, Janssen, Sanofi, AstraZeneca
LEADERSHIP
Key Executives:
Jim Wu - Founder & CEO
Haiqing Yuan - Chief Scientific Officer
Scientific Founders:Jim Wu
Board Members:Jim Wu, Representatives from TPG and Qiming Venture Partners
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Ark Biosciences. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.